First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Reaches New 12-Month High – What’s Next?

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)’s share price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $229.55 and last traded at $229.1060, with a volume of 1277 shares traded. The stock had previously closed at $226.42.

First Trust NYSE Arca Biotechnology Index Fund Stock Up 1.8%

The business has a 50-day moving average price of $212.20 and a 200-day moving average price of $209.43. The company has a market capitalization of $2.60 billion, a price-to-earnings ratio of 21.72 and a beta of 0.68.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

A number of institutional investors have recently bought and sold shares of the business. Dynamic Wealth Strategies LLC boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 10.8% during the 4th quarter. Dynamic Wealth Strategies LLC now owns 515 shares of the company’s stock worth $106,000 after acquiring an additional 50 shares during the period. Sequent Planning LLC boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 4.5% during the 1st quarter. Sequent Planning LLC now owns 1,150 shares of the company’s stock worth $231,000 after acquiring an additional 50 shares during the period. Kestra Private Wealth Services LLC boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 0.6% during the 4th quarter. Kestra Private Wealth Services LLC now owns 8,919 shares of the company’s stock worth $1,842,000 after acquiring an additional 53 shares during the period. Signaturefd LLC boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 30.6% during the 4th quarter. Signaturefd LLC now owns 235 shares of the company’s stock worth $49,000 after acquiring an additional 55 shares during the period. Finally, Bedell Frazier Investment Counselling LLC boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 1.8% during the 3rd quarter. Bedell Frazier Investment Counselling LLC now owns 3,200 shares of the company’s stock worth $574,000 after acquiring an additional 57 shares during the period.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.